跳至主要内容
临床试验/NCT07116551
NCT07116551进行中(未招募)不适用

Abbott BE TAVI Early Feasibility Study: Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis

Abbott Medical Devices8 个研究点 分布在 2 个国家目标入组 11 人开始时间: 2025年10月30日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
11
试验地点
8
主要终点
Technical success

研究概览

简要总结

The purpose of this study is to evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.

详细描述

The EFS will evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is at least 18 years of age
  • Subject is able and willing to return for required follow-up visits and assessments
  • Degenerative severe aortic valve stenosis of the native aortic valve with echo-derived criteria

排除标准

  • Pregnant or nursing subjects
  • Life expectancy for a condition other than aortic stenosis is less than 2 years
  • Presence of other anatomic or comorbid conditions
  • Incapacitated individuals
  • Evidence of an acute myocardial infarction
  • Untreated clinically significant coronary artery disease requiring revascularization
  • Liver failure
  • Severe mitral regurgitation or severe mitral stenosis

研究组 & 干预措施

BE TAVI System

Experimental

BE TAVI System

干预措施: Abbott BE TAVI System (Device)

结局指标

主要结局

Technical success

时间窗: From start of procedure up to end of procedure

Successful access, delivery of the Abbott BE TAVI valve, and retrieval of the delivery system.

Device success

时间窗: 30 days

Intended performance of the valve

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Early Feasibility Study (EFS) of Abbott's... | 临床试验